Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
PENGUMUMAN
RAPAT UMUM PEMEGANG SAHAM LUAR BIASA
Dengan ini diumumkan kepada para Pemegang Saham PT Organon Pharma Indonesia Tbk
(“Perseroan”), berkedudukan di Sinarmas MSIG Tower, Lantai 37 Unit 102 & 106 Jl. Jend. Sudirman
Kav. 21 Setiabudi, Jakarta Selatan, DKI Jakarta, bahwa Perseroan akan menyelenggarakan Rapat
Umum Pemegang Saham Luar Biasa (selanjutnya disebut “RUPSLB”) (selanjutnya disebut “Rapat”) di
Jakarta pada hari Kamis, 20 Agustus 2026.
Sesuai dengan ketentuan dalam Pasal 10 ayat 5 Anggaran Dasar Perseroan serta memperhatikan
Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana dan Penyelenggaraan
Rapat Umum Pemegang Saham Perusahaan Terbuka (“POJK No. 15”), Pemanggilan Rapat akan
dilakukan pada 30 Juli 2026 melalui situs web Bursa Efek Indonesia, dan situs web Perseroan.
Yang berhak menghadiri/mewakili dalam Rapat adalah Pemegang Saham Perseroan yang namanya
tercatat dalam Daftar Pemegang Saham Perseroan pada tanggal 29 Juli 2026, pukul 16.00 Waktu
Indonesia Barat (WIB) atau pemilik saham Perseroan pada sub rekening efek PT Kustodian Sentral
Efek Indonesia (KSEI) pada penutupan perdagangan saham di Bursa Efek Indonesia (BEI) tanggal 29
Juli 2026, pukul 16.00 WIB.
Seorang Pemegang Saham atau lebih yang (bersama-sama) mewakili 1/20 (satu per dua puluh) atau
lebih dari jumlah seluruh saham Perseroan dengan hak suara yang sah yang telah dikeluarkan oleh
Perseroan dapat mengajukan usulan mata acara Rapat. Usulan Pemegang Saham Perseroan tersebut
akan dimasukan dalam mata acara Rapat jika memenuhi ketentuan Pasal 10 ayat 21 Anggaran Dasar
Perseroan dan Pasal 16 POJK No. 15, yakni:
1. Usul tersebut diajukan tertulis dan diterima Direksi Perseroan paling lambat tanggal 23 Juli 2026
pukul 16.00 Waktu Indonesia Barat;
2. Disertai alasan dan bahan usulan mata acara Rapat;
3. Usul tersebut merupakan mata acara yang membutuhkan Keputusan Rapat serta tidak
bertentangan dengan peraturan perundang-undangan; dan
4. Usul tersebut dilakukan dengan itikad baik, mempertimbangkan kepentingan Perseroan dan
berhubungan langsung dengan usaha Perseroan.
Pengumuman Rapat ini juga dapat diakses pada situs web PT Kustodian Sentral Efek Indonesia
(www.ksei.co.id), situs web Bursa Efek Indonesia (www.idx.co.id), dan situs web Perseroan
(https://www.organon.com/indonesia/).
Jakarta, 16 Juli 2026
PT ORGANON PHARMA INDONESIA Tbk
Direksi
Page 2
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
ANNOUNCEMENT OF THE
EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
It is hereby announced to the Shareholders of PT Organon Pharma Indonesia Tbk (the "Company"),
domiciled at Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Setiabudi,
Jakarta Selatan, DKI Jakarta, that the Company will hold an Extraordinary General Meeting of
Shareholders (“EGMS”) (hereinafter referred to as the "Meeting") in Jakarta on Thursday, 20
August 2026.
In accordance with the provisions of Article 10 paragraph 5 of the Company's Articles of Association
and Financial Services Authority Regulation Number 15/POJK.04/2020 concerning Plans and
Implementation of General Meeting of Shareholders of Public Companies ("POJK No. 15"), the
invitation to the Meeting will be made on 30 July 2026 through the website of the Indonesia Stock
Exchange, and the Company's website.
Those entitled to attend/represent the Meeting are the Company's Shareholders whose names are
registered in the Company's Shareholders Register on 29 July 2026, 16.00 Western Indonesia Time
(WIB) or the Company's shareholders in the securities sub account of PT Kustodian Sentral Efek
Indonesia (KSEI) at the close of trading day on the Indonesia Stock Exchange (IDX) on 29 July 2026,
16.00 WIB.
One or more Shareholders who (together) represent 1/20 (one twentieth) or more of the total
number of shares of the Company with valid voting rights that have been issued by the Company
may propose a meeting agenda. The proposal of the Company's Shareholders will be included in the
agenda of the Meeting if it meets the provisions of Article 10 paragraph 3 of the Company's Articles
of Association and Article 16 of POJK No. 15, namely:
1. The proposal must be submitted in writing and received by the Board of Directors of the Company no later
than 23 July 2026 at 16.00 Western Indonesia Time;
2. The proposal must be accompanied by the reasons and supporting materials for the proposed meeting
agenda item;
3. The proposal must constitute an agenda item that requires a resolution of the Meeting and must not conflict
with the prevailing laws and regulations; and
4. The proposal must be submitted in good faith, taking into account the interests of the Company, and must be
directly related to the Company’s business activities .
The announcement of this Meeting can also be accessed on the website of the Indonesian Central
Securities Depository (www.ksei.co.id), the website of the Indonesia Stock Exchange
(www.idx.co.id), and the Company's website (https://www.organon.com/indonesia/).
Jakarta, 16 July 2026
PT ORGANON PHARMA INDONESIA Tbk
Board of Directors
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1 ×5
unresolved
org
Financial Services Authority
p.2
unresolved
org
Indonesia Stock Exchange
p.2 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.222
139 ms
12 Sep 2026 19:15
Raw output
{'agenda': [],
'is_electronic': False,
'meeting_date': '2026-08-20',
'meeting_type': 'EGM'}